Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

ASSA13-14-16 Influence of Amlodipine on Tacrolimus Concentration/Dose in Hypertension Patients During Perioperative Period After Kidney Transplantation

View through CrossRef
Objective To investigate the prevalence of hypertension during perioperative period after kidney transplantation, observe the influence of amlodipine on tacrolimus steady-state concentration/dose (ng·mg-1·Kg, dose imply Dose/Body Weight). Methods Select kidney transplantation patients using Tacrolimus + Mycophenolate Mofetil (Or Mycophenolate sodium enteric-coated tablets) + Glucocorticoid as triple immunosuppressive therapy during May 2012 and December 2012. After in vivo tacrolimus reach the steady-state, collect the peripheral vein blood just before and 0.5 h, 1 h, 2 h, 8 h, 12 h after administration to detect the blood concentration of tacrolimus. After sampling, hypertension patients will be given amlodipine 5mg/d (140mmHg ≤ SBP ≤ 150mmHg) or 10mg/d (SBP ≥ 160mmHg). If blood pressure is higher than normal before this, other kinds of antihypertensive medicine except CCB should be given to control it. One week after amlodipine medication, collect the peripheral vein blood just before and 0.5 h, 1 h, 2 h, 8 h, 12 h after administration to detect the blood concentration of tacrolimus. Compare the tacrolimus concentration/dose (C/D) of different time points before and after amlodipine combination, analyse the influence of amlodipine on tacrolimus. Results There are 60 (43 male, 17 female) patients included, 55 (40 male, 15 female) hypertension patients among them. 31 (19 male, 12 female) patients complete the sampling. Tacrolimus C/Ds of 0 h, 0.5 h, 1 h, 2 h, 8 h and 12 h before and after amlodipine combination were 57.47 ± 7.35 and 72.91 ± 12.29 (p = 0.136), 175.17 ± 31.19 and 132.44 ± 28.65 (p = 0.144), 167.61 ± 17.52 and 200.01 ± 35.44 (p = 0.208), 119.63 ± 14.40 and 195.89 ± 34.66 (p = 0.018), 63.75 ± 7.99 and 92.00 ± 11.89 (p = 0.006), 54.82 ± 9.17 and 79.92 ± 19.23 (p = 0.072), respectively. C/Ds of each time point elevated except 0.5 h after amlodipine medication, especially 2 h and 8 h had significant difference. Conclusions The incidence of hypertension during perioperative period after kidney transplantation is 92%. Combine tacrolimus with amlodipine in these patients will significantly increase its C/D. We should be alert when these two drugs combined in clinical.
Title: ASSA13-14-16 Influence of Amlodipine on Tacrolimus Concentration/Dose in Hypertension Patients During Perioperative Period After Kidney Transplantation
Description:
Objective To investigate the prevalence of hypertension during perioperative period after kidney transplantation, observe the influence of amlodipine on tacrolimus steady-state concentration/dose (ng·mg-1·Kg, dose imply Dose/Body Weight).
Methods Select kidney transplantation patients using Tacrolimus + Mycophenolate Mofetil (Or Mycophenolate sodium enteric-coated tablets) + Glucocorticoid as triple immunosuppressive therapy during May 2012 and December 2012.
After in vivo tacrolimus reach the steady-state, collect the peripheral vein blood just before and 0.
5 h, 1 h, 2 h, 8 h, 12 h after administration to detect the blood concentration of tacrolimus.
After sampling, hypertension patients will be given amlodipine 5mg/d (140mmHg ≤ SBP ≤ 150mmHg) or 10mg/d (SBP ≥ 160mmHg).
If blood pressure is higher than normal before this, other kinds of antihypertensive medicine except CCB should be given to control it.
One week after amlodipine medication, collect the peripheral vein blood just before and 0.
5 h, 1 h, 2 h, 8 h, 12 h after administration to detect the blood concentration of tacrolimus.
Compare the tacrolimus concentration/dose (C/D) of different time points before and after amlodipine combination, analyse the influence of amlodipine on tacrolimus.
Results There are 60 (43 male, 17 female) patients included, 55 (40 male, 15 female) hypertension patients among them.
31 (19 male, 12 female) patients complete the sampling.
Tacrolimus C/Ds of 0 h, 0.
5 h, 1 h, 2 h, 8 h and 12 h before and after amlodipine combination were 57.
47 ± 7.
35 and 72.
91 ± 12.
29 (p = 0.
136), 175.
17 ± 31.
19 and 132.
44 ± 28.
65 (p = 0.
144), 167.
61 ± 17.
52 and 200.
01 ± 35.
44 (p = 0.
208), 119.
63 ± 14.
40 and 195.
89 ± 34.
66 (p = 0.
018), 63.
75 ± 7.
99 and 92.
00 ± 11.
89 (p = 0.
006), 54.
82 ± 9.
17 and 79.
92 ± 19.
23 (p = 0.
072), respectively.
C/Ds of each time point elevated except 0.
5 h after amlodipine medication, especially 2 h and 8 h had significant difference.
Conclusions The incidence of hypertension during perioperative period after kidney transplantation is 92%.
Combine tacrolimus with amlodipine in these patients will significantly increase its C/D.
We should be alert when these two drugs combined in clinical.

Related Results

Tacrolimus and Mycophenolate Mofetil Provide Effective Immunosuppression in Rat Laryngeal Transplantation
Tacrolimus and Mycophenolate Mofetil Provide Effective Immunosuppression in Rat Laryngeal Transplantation
AbstractObjectives/Hypothesis Tacrolimus is efficacious in several transplantation settings. Some studies have demonstrated improved results using combination therapy with mycophen...
Ranolazine-Tacrolimus Interaction
Ranolazine-Tacrolimus Interaction
Objective: To report the case of a kidney allograft recipient on a stable regimen of tacrolimus who exhibited increased tacrolimus concentrations within 24 hour...
Susceptibilité individuelle à la néphrotoxicité du Tacrolimus après transplantation rénale
Susceptibilité individuelle à la néphrotoxicité du Tacrolimus après transplantation rénale
Le rein est particulièrement exposé à de nombreux composés chimiques dont des médicaments, potentiellement néphrotoxiques. Parmi-eux, le Tacrolimus, un anti-calcineurine largement ...
Possible Amlodipine-Induced Hepatotoxicity After Stem Cell Transplant
Possible Amlodipine-Induced Hepatotoxicity After Stem Cell Transplant
Objective: To report the occurrence of hepatotoxicity in a patient initiated on amlodipine. A review of other reports of amlodipine hepatotoxicity is also provided. Case Summary: A...
The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring
The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring
Abstract: The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring. We sought to determine the influence of ethnic miscegenation o...
GW24-e3137 The etiology investigate of hypertension incidence in children
GW24-e3137 The etiology investigate of hypertension incidence in children
Objectives Through retrospective analysis of related factors of children’s hypertension what is composed by primary hypertension and secondary hypertension diseas...
The Impact of CYP3A5 Genotype on Tacrolimus Pharmacokinetics in Children following Heart Transplant
The Impact of CYP3A5 Genotype on Tacrolimus Pharmacokinetics in Children following Heart Transplant
Abstract Tacrolimus is a first-line immunosuppressant used after solid organ transplantation that suffers from extensive intra- and inter-patient variability and a ...

Back to Top